The U.S. Patent and Trademark Office will be offering a virtual panel discussion on the duty of disclosure and duty of reasonable inquiry on February 23, 2023 from 3:00 pm to 4:00 pm ET. Kimberly Braslow of AstraZeneca & Vice Chair of the AIPLA Food and Drug Committee will moderate a panel consisting of Robert A. Clarke, Mary Till, and Matthew Sked of the USPTO Office of Patent Legal Administration, and Ronald K. Jaicks of the USPTO Office of Enrollment and Discipline. The panel will discuss and answer frequently asked questions that the USPTO has received from stakeholders regarding the duty of disclosure and duty of reasonable inquiry.
Those interested in registering for the webinar can do so here.
Comments